Loss in Biological Technology

Cell Therapeutics Second Quarter Net Loss Decreases 54%; Pixantrone NDA Submitted to the FDA for Approval

SEATTLE, Aug. 6 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) today reported recent achievements and financial results for the second quarter and six months ended June 30, 2009. "The second quarter of 2009 was a transforming quarter for the Co...

SeqWright Expands into the Genetically-Targeted Therapy Field by Partnering with PharmaGenoma to Provide Next-Generation Hair Loss Treatment Genetic Testing

HOUSTON, April 28 /PRNewswire/ -- SeqWright Inc., a CLIA certified and GLP compliant provider of custom genomic and molecular biology services, announced today its entry into the genetically-targeted therapy field through its partnership with PharmaGenoma. SeqWright will be the exclusive genetic ...

Siemens Showcases New Hearing Loss Solutions at AudiologyNOW! Conference

Motion(TM) and Life product lines extended to address individual lifestyle needs DALLAS, April 2 /PRNewswire/ -- Siemens Hearing Instruments, Inc., one of the largest manufacturers of hearing instruments in the world, today announced new product models and enhancements at the American Aca...

Pressure BioSciences, Inc. Reports Record Revenue, Significantly Reduced Operating Loss for the Fourth Quarter of 2008

SOUTH EASTON, Mass., March 4 /PRNewswire-FirstCall/ -- Pressure BioSciences, Inc. (Nasdaq: PBIO ) ("PBI" or the "Company") today announced that total revenue for the fourth quarter of 2008 was $334,041 compared to $174,071 for the comparable period in 2007, a 92% increase. Revenue from the sale...

Peregrine Pharmaceuticals Mourns Loss of Chairman Thomas A. Waltz

TUSTIN, Calif., Dec. 11 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) today announced that Thomas A. Waltz, M.D., chairman of its Board of Directors, unexpectedly passed away on Wednesday. Dr. Waltz had been a director of Peregrine since 2004 and was chairman since 2...

Cell Therapeutics Net Loss Declines as Operating Expenses Decrease By 58% in Third Quarter 2008

Zevalin(R) on Track for Break-Even in 2008 SEATTLE, Nov. 7 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) reported financial results for the quarter ended September 30, 2008. Total revenues for the quarter were $2.6 million compared to $20,000 for...

Nyer Medical Group, Inc. Reports Revenues of $71.2 Million With Net Loss of $.10 Per Share for Fiscal Year 2008

BANGOR, Maine, Oct. 14 /PRNewswire-FirstCall/ -- Nyer Medical Group, Inc. (Nasdaq: NYER ) reported results for the fiscal year ended June 30, 2008. Revenues for the fiscal year ended June 30, 2008 increased $6.6 million or 10.2% to $71.2 million from $64.6 million as reported for the previous...

China Medicine to Showcase 'Bethin' Weight Loss Product at 2008 Natural Products Expo East Trade Show

GUANGZHOU, China, Oct. 13 /Xinhua-PRNewswire/ -- China Medicine Corporation (OTC Bulletin Board: CHME; "China Medicine" or "the Company"), a leading distributor and developer of prescription and over-the-counter pharmaceuticals, traditional Chinese medicines ("TCM"), nutritional and dietary su...

alli(TM) Partners with Breast Cancer Network of Strength(TM) to Support Women Challenged by Breast Cancer, Weight Loss or Both

Research Indicates Being Overweight Increases Risk of Breast Cancer PARSIPPANY, N.J., Sept. 22 /PRNewswire/ -- Who knew that simply putting on 21 - 30 pounds between your teens and your 50s could increase your risk of breast cancer after menopause? Now that word is getting out about the link...

Rutgers neuroscience may hold key to hearing loss remedy

NEW BRUNSWICK, N.J. A Rutgers University team led by neuroscientist Robin Davis is opening new doors to improved hearing for the congenitally or profoundly deaf. Their findings could lead to a new generation of cochlear implants. Cochlear implants today operate with varying degrees of success...

New Drug to Prevent Bone Loss Caused by Breast Cancer Treatment

SAN ANTONIO, Dec. 15 /PRNewswire/ -- Denosumab is a new drug being studied to prevent fractures in breast cancer patients receiving hormonal therapy. Results of a phase 3 clinical trial using denosumab were presented Friday evening at the San Antonio Breast Cancer Symposium by Georgiana Ellis,...

Salugen's Award-Winning Research on Using DNA Information to Customize Nutritional Supplementation for Weight Loss Presented at the Second Annual Bruce Ames International Symposium on Nutritional Genomics at the University of California, Davis

SAN DIEGO, Oct. 26 /PRNewswire/ -- Salugen, Inc., a personalized health and wellness company presented its research entitled: DNA-customized Genotrim [neuronal dopamine release activator] results in significant reductions in weight, appetite and sugar cravings in an obese population in the Die...

New Data Reveal Ethnicity May Play Role in Weight Loss Decisions

NEW ORLEANS and PITTSBURGH, Oct. 22 /PRNewswire-FirstCall/ -- A new analysis of a landmark weight loss survey suggests that Hispanics and African Americans are more likely than whites to use unproven dietary supplements for weight loss. The data, presented today at the 2007 Annual Scientific M...

Gladstone scientists uncover potential mechanism of memory loss in Alzheimer's disease

SAN FRANCISCO, CA -- September 6, 2007 -- Researchers at the Gladstone Institute of Neurological Disease (GIND) and Baylor College of Medicine have discovered a mechanism by which the protein Amyloid-beta(AB) may impair neurological functions in Alzheimer's disease. AB, which is known to accumulat...

Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results

PETACH-TIKVA, Israel, August 16 /PRNewswire-FirstCall/ -- Healthcare Technologies Ltd. (NASDAQ: HCTL ), today announced unaudited results for the second quarter and six months period ended June 30, 2007. Revenues for the first six months of 2007 were $7.75 million, compared to $7.05 million ...

Mindset BioPharmaceuticals (USA) Inc Obtains Notice of Allowance for European Patent Related to Use of Insulin Sensitizers in Senile Dementia, Dementia and Memory Loss

NEW YORK, Feb. 24 /PRNewswire/ -- Mindset BioPharmaceuticals (USA) Inc ("MINDSET") a company privately held by MPM Capital and other shareholders announced today that it has received a Notice of Allowance in Europe related to patent applications describing the use of insulin sensitizer drugs for t...

GHI Medical Deploys New Test to Help Determine Hair Loss

CLEARWATER, Fla., March 14 /PRNewswire/ -- GHI Medical, a national leader in preventative healthcare testing, is implementing a new method to correlate the results of a current test used to analyze specific causes of hair loss; the test is called the TrichoBioScan(TM). The TrichoBioScan(TM) ...

NIOXIN(R) Delivers the Future to Scalp and Hair Care, Introduces the First Genetic Test to Determine the Likelihood of Hair Loss

Leading Scalp and Hair Care Company Enters Agreement with HairDX to Offer Consumer-Friendly Hair Loss Test ATLANTA, March 6 /PRNewswire/ -- NIOXIN(R) Research Laboratories Inc., the leader in professional skincare for the scalp, today announced that it will offer an easy to a...

Lamenting the loss of leisure

Last weeks column spurred enough e-mail to suggest that I was largely misunderstood when I declared independence from technology (sort of). As one reader stated, the idea of getting independence from technology is as impossible. (He also suggested it was illegal and non-ethical, but Im chalkin...

Sonic Foundry has net loss for '05 despite nearly doubled revenue

Madison, Wis. — Sonic Foundry posted mixed financial numbers for the end of fiscal 2005 on Thursday, nearly doubling revenue while still posting a net loss. Revenues were $8.3 million, an 89 percent increase over the previous fiscal year, with unit sales up 74 percent, owing to multiple ...

Merge Healthcare reports $10.8M net loss in Q3

West Allis, Wis. - Merge Healthcare (Nasdaq: MRGE), a financially embattled medical imaging software company, reported a net loss of $10.8 million, or 32 cents per share, during the third quarter of 2006. The company, which has seen several top executives resign and faced delisting from the ...

Third Wave reports net loss of $18.9M for 2006

Madison, Wis. - Third Wave Technologies reported a smaller net loss of $18.9 million, or 45 cents per share in 2006, but the company experienced impressive growth in clinical molecular diagnostic revenue, according to a year-end financial report. Third Wave, which develops molecular diagnost...

Merge Healthcare suffers $258M loss in `06

West Allis, Wis. - Acknowledging that a return to profitability won't happen until later this year, Merge Healthcare reported an annual net loss of $258.5 million, or $7.67 per diluted share, in a difficult 2006 that saw several executives resigned in the wake of financial reporting errors. ...

Sonic Foundry reports GAAP loss as Q2 revenues rise

Madison, Wis . - Sonic Foundry has reported a GAAP loss of $1.9 million, or five cents per share, for the second quarter of fiscal 2007, but the company's quarterly revenues continue to rise. Sonic Foundry, developer of the Mediasite communications technology, said its Q2 net loss compares to...

Merge Technologies' net loss doubles to $10.1M

West Allis, Wis. - Merge Technologies reported a net loss of $10.1 million, or $0.30 per share, in the first quarter of 2007, more than double the net loss of $4.9 million, or $0.15 per share, in the first quarter of 2006. While the first quarter loss was well below the $27.0 million, or $0....

TomoTherapy reports 86% revenue jump, $131M net loss in Q1

Madison, Wis. - TomoTherapy saw its revenues surge by 86 percent and its net loss grow to $131.1 million, according to the first earnings report issued since it officially became a publicly traded company. The company also announced that it has joined a research collaboration with Lawrenc...

Detection and Identification of Phosphorylation Sites in Proteins Using LC/MS/MS with Neutral Fragment Loss Mapping

Michaela Scigelova, Gary Woffendin; Thermo Finnigan, Hemel Hempstead, UK. Malcolm Ward, Helen Byers; Proteome Sciences, London, UK. Diane Hanger; Institute of Psychiatry KCL, London, UK. ...

IPod, I Run: The technology of weight loss

If you pledged to lose weight in 2005, youre not alone. Its estimated that more than 100 million Americans (and more than 2 million Wisconsinites) made a New Years resolution to lose weight in 2005. The majority of Americans make a health and fitness resolution of some sort and 38 percent of ...

Sonic Foundry posts explosive growth, though still operating at a loss

Madison, Wis. Sonic Foundry reported revenue up 86 percent and a narrowed net loss for its fiscal year. The company makes multimedia presentation hardware and software for business, government and education. Revenue for 2005 was $8.3 million, compared to last year's $4.4 million. The company ...

Third Wave reports clinical growth, continued loss

Madison, Wis. Higher revenue from its clinical molecular diagnostic products could not prevent Third Wave Technologies, Inc. from reporting a loss for the quarter ending March 31, 2006. Third Wave reported total revenues of $7.9 million and a net loss of $4.4 million, or ($0.11) a diluted s...

Rexnord to slash debt after quarterly loss

Milwaukee, Wis. - Following a quarterly net loss of $2.8 million, executive officers at Rexnord Corp. , a manufacturer of motion technology products, said the company is focused on reducing its debt. In a report of first quarter 2007 results, CFO Tom Jansen highlighted increased quarterly sal...

Merge Healthcare appoints new CEO, reports $215 million Q2 loss

West Allis, Wis. - Merge Healthcare , a supplier of medical imaging and information technology, has appointed a new company leader and reported a $215.8 million quarterly loss. Kenneth Rardin has assumed the role of president and CEO of the financially troubled company, replacing interim CEO ...

Third Wave reports $5.2M third quarter loss

Madison, Wis. - Third Wave Technologies, Inc ., has reported a smaller net loss of $5.2 million, or 12 cents per share, thanks in part to higher clinical molecular diagnostic revenue during the third quarter of 2006. Third Wave's net loss for the quarter compared favorably to a net loss of $7...

Fiserv posts 30 percent quarterly loss

Brookfield, Wis. - Citing one-time gains due to Hurricane Katrina and other Gulf Coast storms in late 2005, Fiserv has reported a net loss of nearly $45 million, or 20 cents per share, for the fourth quarter of 2006. The information management services firm reported net income of $105.9 mill...

KV Pharmaceutical Announces Stockholder Action to Amend By-Laws is Invalid

...he Company's Form 8-K filed with the SEC on February 30, 2009; (25) delays in returning certain or many of the Company's products to market, including loss of market share as a result of the suspension of shipments, and related costs; (26) sale or licensing of certain assets; (27) the ability to monetize ...

SCOLR Pharma, Inc. Reports Second Quarter 2009 Financial Results

...rest income due to lower cash balances. Net loss decreased 26%, or $540,603 to $1.6 million for the....1 million for the same period in 2008 and the net loss for the six months ended June 30, 2009, decreased ..., or $628,477 to $3.5 million, compared with a net loss of $4.1 million for the same period in 2008. These...

Novavax Reports Second Quarter 2009 Financial Results

...vavax, Inc. (Nasdaq: NVAX ) today reported a net loss of $8.5 million, or $0.10 per share, for the second quarter of 2009 compared to a net loss of $9.4 million, or $0.15 per share, for the secon...months ended June 30, 2009, Novavax reported a net loss of $16.9 million, or $0.22 per share, as compared ...

Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results

...er ended June 30, 2009, the Company reported a net loss of $1,761,887, or $0.13 per basic and diluted share, compared to a net loss of $2,377,440, or $0.19 per basic and diluted shar...hs ended June 30, 2009, the Company reported a net loss of $4,793,088, or $0.34...

NeurogesX Reports Second Quarter 2009 Results

...n the United States and European Union. Net loss for the second quarter of 2009 was approximately $5.4 million, compared to a net loss of approximately $6.9 million for the second quarter of 2008. Net loss per share attributable to common stockholders was ...

AutoImmune Inc. Reports 2009 Second Quarter Financial Results

...c. (OTC Bulletin Board: AIMM) today reported a net loss of $86,000, or $0.01 per share basic and diluted, ...ee months ended June 30, 2009, compared with a net loss of $86,000, or $0.01 per share basic and diluted, ...8. For the six months ended June 30, 2009, the net loss was $256,000, or $0.02 per share basic and diluted...